Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Discloure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services Ltd, has received a suspension order for a Drug License of a store in Mallapur, Telangana. The suspension is for three days and was issued by the Assistant Director, Drugs Control Administration, Shameerpet, Telangana. The order was received on May 15, 2026. The action was taken under Rule 65 of the Drugs and Cosmetics Act, 1940 and Drugs and Cosmetics Rules, 1945. The company has disclosed a potential revenue loss of Rs 2.49 lakh due to this suspension.
The impact is minimal as only one store is affected for three days with a small estimated revenue loss of Rs 2.49 lakh. However, it signals a regulatory compliance issue that investors should monitor for any recurrence.